Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

These 10 U.S. States Are Best Prepared for a Deep Recession

This week Treasury Secretary Steven Mnuchin called out “mismanaged” states, suggesting that the federal government should not be responsible for bailing out states that had poorly managed budgets before the coronavirus pandemic brought business activ...
Frank Holmes | April 29, 2020 |

A Real Blockchain Developer goes live, eXeBlock Technology (CSE:XBLK)

Last night I attended the Grit Capital's Banking on Blockchain event in Vancouver, along with seemingly every person I've ever met in this city's financial scene. The place was packed - standing room only in a ballroom that usually seats 300+. HIVE Blockchain (HIVE.V) ...
Chris Parry | November 17, 2017 |

Dermira's Phase 2b Atopic Dermatitis Trial Results Send Shares 25% Higher

Dermira shares traded higher today after the firm released positive data from its phase 2b study of lebrikizumab in patients with atopic dermatitis at the Las Vegas Fall Clinical Dermatology Conference. Yesterday afternoon, Dermira Inc. (DERM:NASDAQ) , a biopharmaceu...
Streetwise Reports | October 21, 2019 |

Chimerix Shares Rise 50% as FDA Gives 'Go Ahead' for Phase 2/3 ALI Study in COVID-19 Patients

Shares of Chimerix Inc. traded higher after the company reported it has received U.S. FDA clearance to initiate a Phase 2/3 Study of dociparstat sodium in acute lung injury for patients afflicted with severe COVID-19. Biopharmaceutical company Chimerix Inc....
Streetwise Reports | April 29, 2020 |

BioNTech, CureVac, Valeo Pharma - COVID-19 wakes up the industry

In the past, people have accepted that it usually takes about ten years to get a vaccine on the market. Careful testing with proof of success is required for a preparation to receive approvals. Since COVID-19, the pressure to develop has increased dramatically and also the pot...
Mario Hose | September 1, 2020 |

Neurotrope's Shares Double on Phase 2 Alzheimer's Study Data and $2.7 Million NIH Grant

Neurotrope's shares traded higher today after reporting results from its Phase 2 "203" clinical trial of Byrostatin-1 for treatment of moderately severe to severe Alzheimer's patients. The firm has also been awarded a $2.7 million grant from the National Institutes of Health t...
Streetwise Reports | January 23, 2020 |

I'm Mad as Hell: Long Live Howard Beale

In the 1976 movie "Network," British actor Peter Finch won an Academy Award for his stunning portrayal of news anchorman Howard Beale, whose on-air descent into insanity, prompted by the social and economic conditions of the times, is now legendary. The iconic scene whe...
Streetwise Reports | November 5, 2019 |

Buzz on the Bullboards: Tangible growth stocks

This week, Canada’s main stock index, the TSX , hit a record high thanks to gains in technology and bank stocks. What the “Buzz” Our Bullboards have up to 2 million pageviews a day. Get the inside scoop on conv...
Trevor Abes | December 4, 2024 |

Daimler, dynaCERT, NEL, Tesla - who will double the share price in 2020?

In the past few weeks, many vehicles have come to a standstill. Despite the decrease in traffic, pollution levels at measuring stations in German city centres have not decreased, as reported in the media. Detached from this realization, politicians are bringing a scrapping bon...
Mario Hose | May 7, 2020 |

Barrick Gold, Desert Gold, Gazprom: Using volatility wisely

The stock exchange is not a one-way street, and for this reason, there are also fluctuations in price formation. There is no such thing as a fair valuation that statically determines the value of a share. Every investor has different motives in investment decisions and about t...
Mario Hose | October 2, 2020 |
1 2 3 4 5 6 7 8 9 10 ...